Daniela M. Zisterer

3.0k total citations
114 papers, 2.5k citations indexed

About

Daniela M. Zisterer is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Daniela M. Zisterer has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Organic Chemistry, 62 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Daniela M. Zisterer's work include Cancer therapeutics and mechanisms (29 papers), Synthesis and biological activity (23 papers) and Synthesis of β-Lactam Compounds (20 papers). Daniela M. Zisterer is often cited by papers focused on Cancer therapeutics and mechanisms (29 papers), Synthesis and biological activity (23 papers) and Synthesis of β-Lactam Compounds (20 papers). Daniela M. Zisterer collaborates with scholars based in Ireland, Italy and Saudi Arabia. Daniela M. Zisterer's co-authors include D. Clive Williams, Mary J. Meegan, Giuseppe Campiani, Lisa M. Greene, Niamh M. O’Boyle, David G. Lloyd, M.J. Carr, Mark Lawler, Seema M. Nathwani and Vito Nacci and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and FEBS Letters.

In The Last Decade

Daniela M. Zisterer

113 papers receiving 2.4k citations

Peers

Countries citing papers authored by Daniela M. Zisterer

Since Specialization

Citations

This map shows the geographic impact of Daniela M. Zisterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela M. Zisterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela M. Zisterer more than expected).

Fields of papers citing papers by Daniela M. Zisterer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela M. Zisterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela M. Zisterer. The network helps show where Daniela M. Zisterer may publish in the future.

Co-authorship network of co-authors of Daniela M. Zisterer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela M. Zisterer. A scholar is included among the top collaborators of Daniela M. Zisterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela M. Zisterer. Daniela M. Zisterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer 2025 ·Pharmaceuticals ·(unknown), Azizah M. Malebari, (unknown), Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, (unknown), Denise Coutinho Endringer, Mary J. Meegan	5
2	Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers 2023 ·Bioorganic Chemistry ·(unknown), Brendan Twamley, John E. O’Brien, (unknown), Daniela M. Zisterer, Mary J. Meegan, Niamh M. O’Boyle	5
3	Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches 2022 ·Cancers ·(unknown), Leanne Stevenson, (unknown), (unknown), (unknown), Oliver Keminer, Björn Windshügel, Daniela M. Zisterer, Richard D. Kennedy, Jaine K. Blayney, Richard Turkington	3
4	Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin 2022 ·Cancer Treatment and Research Communications ·(unknown), Maureen J. O’Sullivan, Daniela M. Zisterer	4
5	Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones 2022 ·Pharmaceuticals ·Azizah M. Malebari, (unknown), Brendan Twamley, Darren Fayne, Mohemmed Faraz Khan, (unknown), Niamh M. O’Boyle, Daniela M. Zisterer, Mary J. Meegan	9
6	A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis 2021 ·Pharmacological Research ·Francesca Vanni, (unknown), (unknown), Anna Kabanova, Francesca Cattaneo, Anna Sicuranza, Alessandro Gozzetti, Sandra Gemma, Daniela M. Zisterer, Monica Bocchia, Giuseppe Campiani, Cosima T. Baldari, Stefania Butini, Cristina Ulivieri	1
7	Exploring the Anti-Cancer Mechanism of Novel 3,4′-Substituted Diaryl Guanidinium Derivatives 2020 ·Pharmaceuticals ·Viola Previtali, (unknown), (unknown), (unknown), Daniela M. Zisterer, Isabel Rozas	3
8	The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15 2016 ·Investigational New Drugs ·Paula Kinsella, Lisa M. Greene, Sandra A. Bright, (unknown), Stefania Butini, Giuseppe Campiani, Sebastian Bauer, D. Clive Williams, Daniela M. Zisterer	5
9	β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand 2014 ·Journal of Medicinal Chemistry ·Niamh M. O’Boyle, (unknown), M.J. Carr, Andrew J. S. Knox, Seema M. Nathwani, Shu Wang, Laura Caboni, Daniela M. Zisterer, Mary J. Meegan	49
10	The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells 2014 ·Biochemical Pharmacology ·(unknown), Sandra A. Bright, (unknown), Stefania Butini, Giuseppe Campiani, Anne O’Meara, D. Clive Williams, Daniela M. Zisterer	18
11	The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells 2012 ·International Journal of Oncology ·Joanne Lysaght, Navin Kumar Verma, (unknown), Jacqueline Ryan, Giuseppe Campiani, Daniela M. Zisterer, D. Clive Williams, Paul Browne, Mark Lawler, (unknown)	9
12	Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe 2011 ·European Journal of Medicinal Chemistry ·Niamh M. O’Boyle, M.J. Carr, Lisa M. Greene, (unknown), Andrew J. S. Knox, Thomas McCabe, David G. Lloyd, Daniela M. Zisterer, Mary J. Meegan	38
13	PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells 2010 ·British Journal of Cancer ·(unknown), Paul Browne, Patrick Hayden, Elisabeth Vandenberghe, (unknown), Peter Evans, (unknown), Prerna Tewari, Giuseppe Campiani, Stefania Butini, D. Clive Williams, Daniela M. Zisterer, Mark Lawler, (unknown)	27
14	The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia 2009 ·Cancer Research ·(unknown), (unknown), Lisa M. Greene, Siobhan McGuckin, (unknown), Paul Browne, Stefania Butini, Giuseppe Campiani, Mark Catherwood, Elisabeth Vandenberghe, D. Clive Williams, Daniela M. Zisterer, Mark Lawler	30
15	The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Fiona T. Bane, (unknown), Stephen R. Pennington, Giuseppe Campiani, D. Clive Williams, Daniela M. Zisterer, Margaret M. Mc Gee	10
16	Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators 2008 ·Bioorganic & Medicinal Chemistry ·Irene Barrett, Mary J. Meegan, (unknown), M.J. Carr, Andrew J. S. Knox, Natalia V. Artemenko, (unknown), Daniela M. Zisterer, David G. Lloyd	43
17	Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21 2003 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Jude M. Mulligan, Giuseppe Campiani, Anna Ramunno, Vito Nacci, Daniela M. Zisterer	7
18	Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents 2001 ·Biochemical Society Transactions ·Daniela M. Zisterer, Margaret M. Mc Gee, Giuseppe Campiani, Anna Ramunno, Caterina Fattorusso, (unknown), Mark Lawler, D. Clive Williams	7
19	Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: Lack of involvement of the peripheral-type benzodiazepine receptor 1997 ·The Journal of Steroid Biochemistry and Molecular Biology ·Daniela M. Zisterer, D. Clive Williams	14
20	Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver 1996 ·Biochemical Pharmacology ·Margaret J. Woods, Daniela M. Zisterer, D. Clive Williams	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact